Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Familial multiple sclerosis appears more severe than non-familial

Magnetic resonance images (MRI) of a large group of patients with multiple sclerosis has provided the first evidence that those with a history of MS in their families show more severe brain damage than patients who have no close relatives with the disease.

15 Oct 2007

Cigarette smoking may accelerate disability in multiple sclerosis

Persons with multiple sclerosis who smoke risk increasing the amount of brain tissue shrinkage, a consequence of MS, and the subsequent severity of their disease, new research conducted at the Buffalo Neuroimaging Analysis Center (BNAC) at the University at Buffalo has shown.

15 Oct 2007

New genetic understanding of multiple sclerosis patients response to Copaxone

A group of Israeli scientists from the Technion - Israel Institute of Technology, the Weizmann Institute of Science, and Teva Pharmaceutical Industries have recently identified genes responsible for the positive response of many multiple sclerosis (MS) patients to the drug Copaxone.

11 Oct 2007

Trial of repeated antibiotic therapy for Lyme diseases

Findings from the first placebo-controlled study of chronic cognitive impairment after treated Lyme disease (also known as chronic Lyme encephalopathy) demonstrate that patients report moderate cognitive impairment, physical dysfunction comparable to patients with congestive heart failure, and fatigue comparable to patients with multiple sclerosis.

10 Oct 2007

Antibody repairs myelin in lab study of multiple sclerosis and related disorders

Mayo Clinic researchers have found that a human antibody administered in a single low dose in laboratory mouse models can repair myelin, the insulating covering of nerves that when damaged can lead to multiple sclerosis and other disorders of the central nervous system.

10 Oct 2007

$Accentia announces investigational new drug application for Revimmune for refractory MS$

Accentia announces investigational new drug application for Revimmune for refractory MS

Accentia Biopharmaceuticals has announced that it met with the Food and Drug Administration (FDA) on September 26, 2007 for a scheduled pre-Investigational New Drug (pre-IND) meeting on Revimmune.

10 Oct 2007

Smoking appears to have no effect on the progression of multiple sclerosis

Contrary to an earlier report, smoking appears to have no effect on the progression of multiple sclerosis (MS), according to a study published in the October 9, 2007, issue of Neurology®, the medical journal of the American Academy of Neurology.

9 Oct 2007

New thoracic imaging protocol

University of Cincinnati (UC) radiologists have developed a new technique for capturing images of chest veins that eases diagnosis of venous diseases.

9 Oct 2007

Antibiotic Minocycline shows potential as stroke treatment

People treated with the drug minocycline within six to 24 hours after a stroke had significantly fewer disabilities, according to a study published in the October 2, 2007, issue of Neurology®, the medical journal of the American Academy of Neurology.

2 Oct 2007

Meditation for rheumatoid arthritis

A revered contemplative practice for centuries, meditation has recently inspired research into its therapeutic value for everything from anxiety disorders to heart attack prevention.

29 Sep 2007

Study of bone marrow stem cells in multiple sclerosis

A new pilot clinical trial to test bone marrow stem cell therapy with a small group of patients with multiple sclerosis has started at Frenchay Hospital.

27 Sep 2007

Simulation reveals how body repairs balance after damage

Your body goes to a lot of trouble to make sure you stay upright. But when the brain's neural pathways are impaired through injury, age or illness, muscles are deprived of the detailed sensory information they need to perform the constant yet delicate balancing act required for normal movement and standing.

26 Sep 2007

Fluorescence resonance energy transfer technology shows how cancer may take hold

A team, led by researchers at the Carnegie Institution,* has found a key biochemical cycle that suppresses the immune response, thereby allowing cancer cells to multiply unabated.

26 Sep 2007

Research shows how genetic mutation causes epilepsy in infants

New research from the Howard Florey Institute in Melbourne has shown why mutation in a single gene can cause epilepsy in infants.

24 Sep 2007

Clostridium difficile could outstrip MRSA in Irish hospitals

Research findings on a bug which is a major threat to hospital patients and particularly elderly patients, which could outstrip MRSA, will be presented to the Irish Society for Immunology (ISI) Annual Conference at Dublin City University.

24 Sep 2007

Cell-surface sugar defects may trigger nerve damage in multiple sclerosis patients

Defects on cell-surface sugars may promote the short-term inflammation and long-term neurodegeneration that occurs in the central nervous system of multiple sclerosis patients, according to University of California, Irvine researchers.

21 Sep 2007

Weill Cornell Medical College to lead new NYC translational research collaboration

Weill Cornell Medical College has been selected by the National Center for Research Resources (NCRR), of the National Institutes of Health (NIH), to establish and lead a new Clinical and Translational Science Center (CTSC), creating an ambitious and innovative network for biomedical collaboration on New York's Upper East Side.

20 Sep 2007